Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials
Molecules · 30.06.2023 · 28 (13) · 5145
DOI: 10.3390/molecules28135145 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 30.06.2023. Verfasst von Manman Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 173-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National TCM Inheritance Innovation Team Project, the Major Tackling Project of Science and Technology Innovation Project of China Academy of Chinese Medical Sciences.
Abstract (Originalsprache)
Cancer continues to pose a severe threat to global health, making pursuing effective treatments more critical than ever. Traditional therapies, although pivotal in managing cancer, encounter considerable challenges, including drug resistance, poor drug solubility, and difficulties targeting tumors, specifically limiting their overall efficacy. Nanomedicine’s application in cancer therapy signals a new epoch, distinguished by the improvement of the specificity, efficacy, and tolerability of cancer treatments. This review explores the mechanisms and advantages of nanoparticle-mediated drug delivery, highlighting passive and active targeting strategies. Furthermore, it explores the transformative potential of nanomedicine in tumor therapeutics, delving into its applications across various treatment modalities, including surgery, chemotherapy, immunotherapy, radiotherapy, photodynamic and photothermal therapy, gene therapy, as well as tumor diagnosis and imaging. Meanwhile, the outlook of nanomedicine in tumor therapeutics is discussed, emphasizing the need for addressing toxicity concerns, improving drug delivery strategies, enhancing carrier stability and controlled release, simplifying nano-design, and exploring novel manufacturing technologies. Overall, integrating nanomedicine in cancer treatment holds immense potential for revolutionizing cancer therapeutics and improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
- Department of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China.
ORCID-Profile: Manman Xu, Xinpu Han, Hongtai Xiong, Yijie Gao, Bowen Xu, Guanghui Zhu, Jie Li
Förderung
- National Natural Science Foundation of China
- National TCM Inheritance Innovation Team Project
- the Major Tackling Project of Science and Technology Innovation Project of China Academy of Chinese Medical Sciences
- Major Tackling Project of Science and Technology Innovation Project of China Academy of Chinese Medical Sciences
Zitieren
APA
Xu, M., Han, X., Xiong, H., Gao, Y., Xu, B., Zhu, G., & Li, J. (2023). Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials. Molecules, 28(13), 5145. https://doi.org/10.3390/molecules28135145
Vancouver
Xu M, Han X, Xiong H, Gao Y, Xu B, Zhu G, et al. Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials. Molecules. 2023;28(13):5145. doi:10.3390/molecules28135145
BibTeX
@article{Xu2023,
author = {Xu, Manman and Han, Xinpu and Xiong, Hongtai and Gao, Yijie and Xu, Bowen and Zhu, Guanghui and Li, Jie},
title = {Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials},
journal = {Molecules},
year = {2023},
volume = {28},
number = {13},
pages = {5145},
doi = {10.3390/molecules28135145}
}
EUVIMED